Statistics
Publications
1
Citations
57
H-Index
1
Active since
2015
Affiliations
Eli Lilly (United States)(Current)
Javier Agejas Francisco is an author at Eli Lilly (United States) specializing in farnesoid x receptor signaling, treatment targets in dyslipidemia, and atherogenic dyslipidemia management.
Publications per year
2015–2015
1
1
Michaël Génin, Ana B. Bueno, Javier Agejas Francisco et al. · Journal of Medicinal Chemistry · 2015 · 57 citations · Full text
1–1 of 1